|
 Roll
back malaria and other mosquito-borne diseases:
 Providing
technical support to the Ministry of Health for prevention and control of
malaria and other mosquito-borne diseases:
development
of policies, strategies and guidelines;
training;
planning,
implementation, monitoring and evaluation;
development
of information, education and communication strategy and materials;
conduct research.
Advocacy
and resource mobilization.
Coordination
with partners and dissemination of technical information.
Supporting
Ministry of Health and other partners in addressing major issues on malaria
control such as multi-drug resistance, fake/counterfeit drugs, malaria among
migrant workers and ethnic groups, quality assurance of drugs and
diagnostics.
Facilitating
cross-border collaboration.
Facilitating
human resource development through local and international training.
Supporting
morbidity control and mass drug administration for elimination of lymphatic filariasis.
Providing
logistics support
|
Signing of a new grant between Three Diseases Fund
and WHO for scaling up malaria control activities in Myanmar
|
|
|
Since 2006, the
prevention and control of Malaria, one of the public health priorities in Myanmar,
has been further strengthened through the financial support of Three
Diseases Fund (3DF) Programme, along with the
technical assistance from WHO. To date 3 DF programme has supported approximately USD 9 million for
Malaria control efforts in Myanmar.
More Information
|
|
Workshop to review and plan therapeutic efficacy
surveys to monitor P. falciparum and P. vivax resistance to antimalarial
drug in the Greater Mekong Subregion
|
|
The Myanmar National Malaria Control Programme,
in collaboration with WHO Country Office, hosted the workshop to review and plan
therapeutic efficacy surveys to monitor P. falciparum
and P. vivax resistance to antimalarial
drug in the Greater Mekong Subregion in Mandalay, September 30
- October 2, 2009…
More Information
|
|
Experts Recommend Actions to Prevent the Emergence
and Spread of Anti-malarial Drugs Resistance in Myanmar
|
|
The Department of Medical Research (Lower Myanmar), in collaboration
with WHO, successfully concluded a Technical Meeting on Anti-malarial Drug
Resistance in Myanmar on 13 March 2009. Experts on malaria from national
and international organizations and representatives from Food and Drug
Administration and the pharmaceutical companies in Myanmar
participated. They concluded that treatment failure rates to artemisinin-based combination treatments (ACTs) is high, and the prolonged parasite clearance
time documented in seven cases is a concern. However, it was not clear if
the treatment failures and the prolonged parasite clearance time were due
to Plasmodium falciparum resistance to artemisinins since pharmacokinetic studies were not
done and Polymerase Chain Reaction (PCR) analysis was only done for studies
carried out in 2007. Previous
report on two cases of P. vivax malaria resistant
to chloroquine was noted. Further studies are needed to validate
resistance of P. vivax to chloroquine
and to determine the magnitude.
More Information
|
|
|
|
Improving Quality of Management of Malaria by the
Private General Practitioners
|
|
The case management of malaria by the general
practitioners (GPs) is being improved through Quality Diagnosis and
Standard Treatment of Malaria Project.
It is being implemented by Myanmar Medical Association (MMA) with
financial grant from Three Diseases Fund and with technical and management
support by WHO. In addition, the
WHO Mekong Malaria Programme provides support to
MMA to promote to GPs nationwide the rational use of recommended antimalarial drugs as per national malaria treatment
policy.
More Information
|
|
MCC-WHO-3DF community-based malaria control: progress
and challenges
|
|
|
Empowered village health volunteers are making
significant contributions towards malaria control, there is no more death
attributed to malaria in their respective communities and the villagers
appreciated very much their services. These sum up
the progress to date of community-based malaria control project in 160
remote hard to reach villages being implemented by the Myanmar Council of
Churches (MCC). It is financially supported by Three Diseases Fund (3DF),
and with technical and management support by WHO.
More Information
|
|
Publications
|
|
Malaria in the Greater Mekong Subregion: Regional
and Country Profiles
 This report provides an overview of
the epidemiological patterns of malaria in the Greater Mekong Subregion (GMS) from 1998 to 2007, and highlights
critical challenges facing National Malaria Control Programmes
and partners as they move towards malaria elimination as a programmatic
goal.
Full document [pdf]
|
|
|
|
|
